Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinoma
The confounding effects of next-generation sequencing (NGS) noise on detection of low frequency circulating tumor DNA (ctDNA) without a priori knowledge of solid tumor mutations has limited the applications of circulating cell-free DNA (ccfDNA) in clinical oncology. Here, we use a 118 gene panel and...
Main Authors: | Kajsa E. Affolter, Sabine Hellwig, David A. Nix, Mary P. Bronner, Alun Thomas, Carrie L. Fuertes, Cindy L. Hamil, Ignacio Garrido-Laguna, Courtney L. Scaife, Sean J. Mulvihill, Hunter R. Underhill |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558621000452 |
Similar Items
-
Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA
by: Jee‐Soo Lee, et al.
Published: (2019-08-01) -
Prognostic impact of circulating tumor DNA detection in portal and peripheral blood in resected pancreatic ductal adenocarcinoma patients
by: Charlotte Maulat, et al.
Published: (2024-11-01) -
Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma
by: Daniel C. Osei-Bordom, et al.
Published: (2022-01-01) -
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma
by: Maria Cristina Curia, et al.
Published: (2019-05-01) -
Caso Clínico Tumor Mucinoso Papilar Intra Ductal del Páncreas
by: Iván Nieto Orellana, et al.
Published: (2019-04-01)